| Canada exports to USA · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Hormones and steroids used primarily as hormones: oestrogens and progestogens | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Hormones and steroids used primarily as hormones: (other than insulin and its salts, oestrogens and progestogens) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Sugars: chemically pure, other than sucrose, lactose, maltose, glucose and fructose: sugar ethers and sugar esters, and their salts, other than products of heading no. 2937, 2938 or 2939 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Sugars: chemically pure, other than sucrose, lactose, maltose, glucose and fructose: sugar ethers and sugar esters, and their salts, other than products of heading no. 2937, 2938 or 2939 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Antibiotics: penicillins and their derivatives with a penicillanic acid structure: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Antibiotics: n.e.s. in heading no. 2941 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ireland · Antibiotics: n.e.s. in heading no. 2941 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Antibiotics: n.e.s. in heading no. 2941 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to India · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Trinidad and Tobago · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Colombia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Czechia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Argentina · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ireland · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Austria · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Rep. of Korea · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Malaysia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Netherlands · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Pakistan · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to India · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Spain · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Sweden · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Brazil · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Türkiye · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Colombia · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ecuador · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Argentina · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Guatemala · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China, Hong Kong SAR · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Israel · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Other Asia, nes · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Philippines · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Bolivia (Plurinational State of) · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Brazil · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Thailand · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Chile · Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Czechia · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Denmark · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Argentina · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Israel · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Italy · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Rep. of Korea · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Netherlands · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to New Zealand · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Norway · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Poland · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Spain · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Sweden · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Türkiye · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ukraine · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Medicaments: containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ireland · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Italy · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Rep. of Korea · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Netherlands · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Brazil · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Tunisia · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Grenada · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Guyana · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China, Hong Kong SAR · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Jamaica · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Saint Lucia · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Singapore · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Trinidad and Tobago · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Belize · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
Research Data